Comparative study of two vaccines against neonatal diarrhea on a Canadian commercial farm

Home Knowledge Comparative study of two vaccines against neonatal diarrhea on a Canadian commercial farm

Comparative study of two vaccines against neonatal diarrhea on a Canadian commercial farm


The aim of this study was to assess and compare the safety and efficacy performance of two commercial vaccines registered in Canada, under field conditions, on a commercial farm where E. coli was found to be the source of diarrhea.

About this article

Appeared in

AASV Congress, 2017

Authors

Ariza, W.; Robles, D.; Badia, J.; Torrents, D.; Bernal, I.

Summary

This study shows differing diarrhea-preventive effects of the two vaccines evaluated. SUISENG® vaccine exhibited a 6-fold lower incidence of diarrhea in suckling piglets from gilts vaccinated with it than in suckling piglets from gilts vaccinated with its competitor, Vaccine B. SUISENG® vaccine also showed greater safety than Vaccine B by causing a smaller increase in post-vaccination body temperature and by not showing any local or general type reactions, which may end in abortion.

Related products

Share this on

The contents of this page are country specific and aimed specifically at prescribing veterinarians.

This product is not available in {{ preferredCountry.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

Confirm that you are a veterinary professional:

This product is not available in {{ countrySelect.title }}.

You will be redirected to our global site. Click on continue to visit our global site (available in English).

  • I am a veterinarian (otherwise please contact a veterinary professional)

Select your country:

Country {{countrySelect.title}}
  • Global (available in English)
  • {{country.title}}